Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...

A new concept for targeted cancer treatment has proven somewhat successful in mice thus far. The concept relies on using radioactive ion beams to target cancerous tumors and cells directly.

Verastem Oncology (NASDAQ:VSTM) announced on Wednesday that the U.S. FDA has cleared the investigational new drug application of VS-7375, its oral KRAS G12D inhibitor. An oral KRAS G12D inhibitor ...

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer ... The Pfizer logo is seen at the company's world headquarters in New York on April 28, ...

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer ... The Pfizer logo is seen at the company's world headquarters in New York on April 28, ...

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer ... The Pfizer logo is seen at the company's world headquarters in New York on April 28, ...

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer ... The Pfizer logo is seen at the company's world headquarters in New York on April 28, ...

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer ... The Pfizer logo is seen at the company's world headquarters in New York on April 28, ...